Yubo International Biotech YBGJ Balance Sheet (2009-2026)

OTC YBGJ
$0.01 +0.00 (+0.00%)
At close: Nov 12, 2026 · 4:00 PM EST
Reported Financials

Yubo International Biotech Quarterly Balance Sheet

Periods 69 quarters
Latest Sep 2026

Yubo International Biotech reported total assets of $0.65M and total liabilities of $3.55M for the quarter ended Sep 2026, down 31.7% year over year. This balance sheet covers 69 quarters of results from Feb 2009 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Feb2009 Nov2009 Feb2010 May2010 Aug2010 Nov2010 Feb2011 May2011 Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Feb2014 May2014 Aug2014 Nov2014 Feb2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Mar2020 May2020 Aug2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
0.03M0.01M0.04M0.09M0.02M0.03M0.01M0.01M0.01M0.06M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Cash & Current Investments
0.03M0.01M0.04M0.09M0.02M0.03M0.01M0.01M0.01M0.06M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Receivables - NetNet Receivables
0.16M0.15M0.15M0.05M0.05M0.06M0.05M0.05M0.08M0.11M0.21M0.22M0.16M0.15M0.12M0.11M0.14M0.13M0.14M0.12M
Receivables - OtherOther Receivables
0.40M0.32M0.30M0.28M0.29M0.29M0.28M0.28M0.29M0.28M0.29M0.29M0.28M0.28M0.28M0.28M0.29M0.29M0.30M0.30M
Receivables
0.56M0.47M0.45M0.33M0.35M0.35M0.33M0.33M0.37M0.40M0.50M0.51M0.44M0.43M0.40M0.40M0.43M0.43M0.44M0.42M
Inventory
0.16M0.15M0.14M0.13M0.32M0.22M0.21M0.21M0.21M0.21M0.09M0.01M0.04M0.04M0.04M0.04M0.02M0.02M0.02M0.02M
Prepaid Assets
0.31M0.27M0.29M0.22M0.06M0.04M0.15M0.17M0.14M0.07M0.18M0.20M0.20M0.21M0.21M0.20M0.21M0.14M0.11M0.12M
Current Assets
1.06M0.91M0.92M0.78M0.75M0.65M0.70M0.71M0.73M0.73M0.76M0.72M0.68M0.69M0.66M0.65M0.67M0.60M0.58M0.58M
Non-Current Assets
Construction in Progress
0.58M0.60M0.57M0.55M0.32M0.32M0.18M0.50M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M
Property, Plant & Equipment (Net)PP&E (Net)
0.64M0.65M0.61M0.59M0.62M0.61M0.52M0.53M0.38M0.34M0.29M0.26M0.21M0.17M0.13M0.08M0.04M0.02M0.02M0.02M
Intangibles
0.05M0.05M0.05M0.09M0.09M0.09M0.08M0.08M0.05M0.06M0.06M0.06M0.05M0.05M0.04M0.04M0.04M0.04M0.04M0.04M
Goodwill & Intangibles
0.05M0.05M0.05M0.09M0.09M0.09M0.08M0.08M0.05M0.06M0.06M0.06M0.05M0.05M0.04M0.04M0.04M0.04M0.04M0.04M
Other Non-Current Assets
0.15M0.09M0.09M0.08M0.12M0.12M0.12M0.12M0.12M0.12M1.08M0.97M0.12M0.04M0.04M0.04M0.02M0.02M0.02M0.02M
Non-Current Assets
3.53M3.56M3.13M2.94M1.60M1.46M1.26M1.19M0.94M0.81M0.97M0.93M0.85M0.48M0.39M0.30M0.18M0.11M0.09M0.07M
Assets
4.59M4.47M4.05M3.72M2.35M2.11M1.96M1.90M1.67M1.55M1.73M1.65M1.53M1.17M1.05M0.95M0.85M0.71M0.67M0.65M
Liabilities
Current Liabilities
Accounts Payables
0.28M0.39M0.69M0.68M0.55M0.38M0.41M0.55M0.83M0.82M0.92M0.91M1.04M0.98M1.05M0.96M1.06M1.10M1.31M1.40M
Notes Payables
Payables
0.28M0.39M0.69M0.68M0.55M0.38M0.41M0.55M0.83M0.82M0.92M0.91M1.04M0.98M1.05M0.96M1.06M1.10M1.31M1.40M
Accumulated Expenses
Other Accumulated Expenses
1.06M1.39M1.22M1.69M1.89M2.16M
Current Taxes
0.08M
Current Deferred Revenue
0.48M0.46M0.48M0.48M0.46M0.45M0.46M0.46M0.43M0.43M0.43M0.44M0.42M0.43M0.43M0.43M0.44M0.45M0.45M0.47M
Total Current Liabilities
2.79M3.31M3.69M2.97M2.52M2.67M2.95M2.87M3.40M3.52M3.95M4.49M4.72M4.78M5.03M2.56M2.79M3.02M3.33M3.55M
Non-Current Liabilities
Non-Current Debt
Minority Interest
0.01M0.10M0.09M0.13M0.02M0.02M0.06M0.01M-0.01M-0.03M-0.05M
Liabilities from Discontinued OperationsLiabilities from Discont. Ops
5.84M
Operating Leases
1.93M1.91M1.61M1.41M0.39M0.28M0.16M0.14M0.12M0.09M0.20M0.21M0.11M0.03M0.01M0.08M0.08M
Other Non-Current Liabilities
0.48M2.39M0.46M0.67M0.56M0.49M0.43M0.20M0.20M0.21M0.85M0.85M0.86M0.87M0.88M0.89M0.94M
Total Non-Current Liabilities
1.93M1.99M2.45M2.29M2.55M2.51M3.08M3.41M3.95M4.49M3.98M3.96M4.04M1.69M1.92M2.12M2.61M
Total Liabilities
4.72M5.23M5.30M4.38M2.91M2.95M3.11M3.00M3.51M3.61M4.15M4.70M4.83M4.81M4.91M2.56M2.80M3.02M3.33M3.55M
Shareholder's Equity
Total Debt
Common Equity
-0.13M-0.76M-1.25M-0.66M-0.57M-0.84M-1.15M-1.10M-1.84M-2.06M-2.42M-3.04M-3.30M-3.65M-3.86M-1.60M-1.95M-2.31M-2.66M-2.90M
Liabilities and Shareholders Equity
4.59M4.47M4.05M3.72M2.35M2.11M1.96M1.90M1.67M1.55M1.73M1.65M1.53M1.17M1.05M0.95M0.85M0.71M0.67M0.65M
Retained Earnings
-2.49M-3.06M-3.56M-3.79M-3.69M-4.01M-4.37M-4.37M-4.89M-5.26M-5.79M-6.37M-6.66M-7.10M-7.33M-7.48M-7.74M-8.01M-8.26M-8.45M
Preferred Shares

Yubo International Biotech Balance Sheet API

Pull Yubo International Biotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=YBGJ&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY